Market revenue in 2023 | USD 814.8 million |
Market revenue in 2030 | USD 1,902.1 million |
Growth rate | 12.9% (CAGR from 2023 to 2030) |
Largest segment | Chromatography systems |
Fastest growing segment | Filters |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chromatography Systems, Filters, Evaporators, Centrifuges, Dryers |
Key market players worldwide | Merck KGaA, Sartorius AG, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Danaher Corp, Repligen Corp, 3M Co, Boehringer Ingelheim, Corning Inc, Lonza Group Ltd, Dover Corp, Asahi Kasei Corp, Eppendorf |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to downstream processing market will help companies and investors design strategic landscapes.
Chromatography systems was the largest segment with a revenue share of 40.68% in 2023. Horizon Databook has segmented the Japan downstream processing market based on chromatography systems, filters, evaporators, centrifuges, dryers covering the revenue growth of each sub-segment from 2018 to 2030.
Bioprocess engineering has changed considerably in Japan during the past few years owing to the country’s entry in production of higher-value products through bioprocessing techniques. These products are generally obtained using cell-culture and recombinant-DNA technology. The Japanese pharmaceutical companies are continuously involved in research and development to manufacture high-value biopharmaceutical products.
In addition, the Japanese government has also provided financial support and directions for research and development to companies for development of biotechnology products. These funds are majorly for the fields of bioreactor design, cell culture, protein engineering, and membrane processing. Japan is also one of the leading countries in Asia Pacific, which has achieved optimal level of automation in both downstream as well as upstream processing.
This has reduced a lot of human-process interface and enhanced the product quality. In addition, Japan has devoted most of its bioprocess-engineering activities to refinement and development of existing technologies that meet international standards.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan downstream processing market , including forecasts for subscribers. This country databook contains high-level insights into Japan downstream processing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account